Adaptimmune Therapeutics

0.22
-0.01 (-5.70%)
At close: Apr 10, 2025, 10:17 AM

Adaptimmune Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for ADAP stock have an median target of 1.5, with a low estimate of 1.4 and a high estimate of 1.75. The median target predicts an increase of 581.82% from the current stock price of 0.22.

Target Low Average Median High
Price $1.4 $1.54 $1.5 $1.75
Change 536.36% 600.00% 581.82% 695.45%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating on Adap... Unlock content with Pro Subscription

Updated Apr 01, 2025

Rating May 24Jul 24Aug 24Nov 24Mar 25Apr 25
Strong Buy 000000
Buy 212421
Hold 000010
Sell 000000
Strong Sell 000000
Total 2 1 2 4 3 1

Financial Forecast this Year

Revenue This Year
45.2M
from 178.03M
Increased by -74.6%
Revenue Next Year
68.74M
from 45.2M
Increased by 52.1%
EPS This Year
-0.08
from -0.05
Increased by -60%
EPS Next Year
-0.36
from -0.08
Increased by -350%